AgeX Therapeutics Inc (AGE)

[saxonia40271]

The price explosion in October 2020, was baseless, and a complete misunderstanding, possibly deliberately circulated by someone on social media. I'm not sure, where it started, only that it started after a meaningless form SC 13D/A. It was a simple formality. Juvenescence already owned almost half of AgeX, before it was even listed. But I share the bullish outlook, even though I don't expect anyone, to have to pay a fortune for longevity. The therapeutics might be obtained by governments around the world, and given to the people, freely. That doesn't make it any less interesting. The actual longevity technology might become independent. It's already in a subsidiary. If you believe, this will all work out, then the potential might be almost limitless, but it could take some patience. And of course, all early stage biotechs are high-risk, but this one definitely has the opportunities to match.